{"id":690167,"date":"2026-04-30T19:56:03","date_gmt":"2026-04-30T19:56:03","guid":{"rendered":"https:\/\/microscopemedia.com\/?p=690167"},"modified":"2026-04-30T19:56:03","modified_gmt":"2026-04-30T19:56:03","slug":"un-nou-tip-de-terapie-ar-putea-ajuta-la-tratarea-cancerului-rezultate-pozitive-dupa-un-prim-studiu","status":"publish","type":"post","link":"https:\/\/microscopemedia.com\/?p=690167","title":{"rendered":"Un nou tip de terapie ar putea ajuta la tratarea cancerului. Rezultate pozitive dup\u0103 un prim studiu"},"content":{"rendered":"
<\/div>\n
\n

Cercetarea, publicat\u0103 joi \u00een revista Cell, a testat o form\u0103 special\u0103 de terapie CAR-T care con\u021bine un num\u0103r mare de limfocite T cu propriet\u0103\u021bi asem\u0103n\u0103toare celulelor stem.<\/p>\n

Aceste celule imune au capacitatea de a supravie\u021bui mai mult timp \u00een organism \u0219i de a genera noi celule capabile s\u0103 atace tumora.<\/p>\n

Rezultate promi\u021b\u0103toare la pacien\u021bi cu forme grave de cancer<\/h2>\n

\u00cen studiu au fost inclu\u0219i 11 pacien\u021bi cu cancere hematologice care fie recidivaser\u0103 dup\u0103 transplant de celule stem, fie nu r\u0103spunseser\u0103 la tratamente anterioare.<\/p>\n

Dintre ace\u0219tia, cinci pacien\u021bi au intrat \u00een remisie complet\u0103, iar un pacient a avut remisie par\u021bial\u0103. Doar un singur caz a prezentat agravarea bolii la scurt timp dup\u0103 tratament.<\/p>\n

Prin compara\u021bie, \u00eentr-un grup anterior tratat cu terapia CAR-T standard, doar 1 din 10 pacien\u021bi ob\u021binuse remisie complet\u0103.<\/p>\n

Doze mai mici \u0219i reac\u021bii adverse reduse<\/h2>\n

Speciali\u0219tii spun c\u0103 noua formul\u0103 pare mai eficient\u0103 chiar \u0219i la doze mai mici dec\u00e2t terapiile CAR-T clasice.<\/p>\n

Un alt avantaj important a fost reducerea efectelor secundare severe, \u00een special a sindromului de eliberare de citokine, una dintre cele mai periculoase complica\u021bii ale terapiei CAR-T.<\/p>\n

Ce este terapia CAR-T<\/h2>\n

Terapia CAR-T presupune recoltarea limfocitelor T din s\u00e2ngele pacientului, modificarea lor genetic\u0103 \u00een laborator pentru a recunoa\u0219te celulele canceroase \u0219i reinfuzarea lor \u00een organism.<\/p>\n

Noua abordare \u00eencearc\u0103 s\u0103 selecteze \u00een special celulele sistemului imunitar care \u201e\u021bin minte\u201d cancerul \u0219i se pot re\u00eennoi, ca celulele stem.<\/p>\n

Urmeaz\u0103 noi teste, inclusiv pentru tumori solide<\/h2>\n

Cercet\u0103torii preg\u0103tesc deja studii suplimentare pentru alte tipuri de cancer, inclusiv sarcoame \u0219i tumori solide, domeniu \u00een care terapiile CAR-T clasice au avut p\u00e2n\u0103 acum rezultate limitate.<\/p>\n

Realizatorii studiului avertizeaz\u0103 \u00eens\u0103 c\u0103 este vorba despre un studiu mic, iar eficien\u021ba tratamentului trebuie confirmat\u0103 \u00een cercet\u0103ri mai ample.<\/p>\n

Totu\u0219i, rezultatele sunt considerate un pas important spre terapii mai puternice \u0219i mai sigure \u00eempotriva cancerului.<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

Cercetarea, publicat\u0103 joi \u00een revista Cell, a testat o form\u0103 special\u0103 de terapie CAR-T care con\u021bine un num\u0103r mare de limfocite T cu propriet\u0103\u021bi asem\u0103n\u0103toare celulelor stem. Aceste celule imune … Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":690168,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/690167"}],"collection":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=690167"}],"version-history":[{"count":0,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/690167\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/media\/690168"}],"wp:attachment":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=690167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=690167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=690167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}